Strata Skin Sciences Q2 2024 GAAP EPS $(0.03) Beats $(0.70) Estimate
Portfolio Pulse from Benzinga Newsdesk
Strata Skin Sciences (NASDAQ:SSKN) reported a Q2 2024 GAAP EPS of $(0.03), significantly beating the analyst consensus estimate of $(0.70) by 95.71%.
August 14, 2024 | 8:48 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Strata Skin Sciences reported a Q2 2024 GAAP EPS of $(0.03), which is significantly better than the analyst consensus estimate of $(0.70). This positive earnings surprise is likely to boost investor confidence and could lead to a short-term increase in the stock price.
The significant earnings beat indicates better-than-expected financial performance, which is likely to positively impact investor sentiment and drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100